Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BJDX NASDAQ:LGMK NASDAQ:NAYA NASDAQ:NDRA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.61-1.8%$1.71$1.46▼$37.50$2.41M0.47660,053 shs45,719 shsLGMKLogicMark$0.00+6.7%$0.01$0.00▼$15.35$1.84M1.4849.95 million shs11.92 million shsNAYANAYA Biosciences$0.80+1.6%$1.42$1.38▼$17.04$534K2.0353,151 shs70,736 shsNDRAENDRA Life Sciences$7.23-10.4%$4.07$2.90▼$168.00$5.96M-0.18534,055 shs151,404 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics-1.83%-3.59%-4.17%-18.69%-94.36%LGMKLogicMark+6.67%-3.03%-20.00%-65.96%-99.98%NAYANAYA Biosciences+3.36%-5.66%-38.79%-58.23%+80,189,900.00%NDRAENDRA Life Sciences-10.41%-18.21%+113.27%+97.00%-99.91%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBJDXBluejay Diagnostics0.9316 of 5 stars0.05.00.00.02.20.00.6LGMKLogicMark0.1385 of 5 stars0.03.00.00.00.00.00.6NAYANAYA BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ANDRAENDRA Life Sciences3.176 of 5 stars3.55.00.00.03.80.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBJDXBluejay Diagnostics 0.00N/AN/AN/ALGMKLogicMark 0.00N/AN/AN/ANAYANAYA Biosciences 3.00Buy$24.002,892.89% UpsideNDRAENDRA Life Sciences 3.00Buy$50.00591.56% UpsideCurrent Analyst Ratings BreakdownLatest NAYA, NDRA, LGMK, and BJDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025NDRAENDRA Life SciencesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$75.00 ➝ $50.00(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBJDXBluejay DiagnosticsN/AN/AN/AN/A$10.34 per shareN/ALGMKLogicMark$9.88M0.19N/AN/A$148.65 per share0.00NAYANAYA Biosciences$6.23M0.09N/AN/A($2.06) per share-0.39NDRAENDRA Life SciencesN/AN/AN/AN/A$4.77 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBJDXBluejay Diagnostics-$7.72M-$379.74N/A∞N/AN/A-322.46%-262.96%8/13/2025 (Estimated)LGMKLogicMark-$14.55M-$223.50N/A∞N/A-141.96%-124.91%-92.05%8/12/2025 (Estimated)NAYANAYA Biosciences-$8.03MN/A0.00∞N/A-119.91%N/A-41.72%8/12/2025 (Estimated)NDRAENDRA Life Sciences-$11.51M-$172.04N/AN/AN/AN/A-140.96%-106.14%8/13/2025 (Estimated)Latest NAYA, NDRA, LGMK, and BJDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025NDRAENDRA Life Sciences-$2.27N/AN/AN/AN/AN/A8/12/2025Q2 2025LGMKLogicMark-$0.03N/AN/AN/A$2.35 millionN/A5/15/2025Q1 2025LGMKLogicMark-$0.03-$0.12-$0.09-$0.12$2.23 million$2.59 million5/13/2025Q1 2025BJDXBluejay DiagnosticsN/A-$3.37N/A-$3.37N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBJDXBluejay DiagnosticsN/AN/AN/AN/AN/ALGMKLogicMarkN/AN/AN/AN/AN/ANAYANAYA BiosciencesN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBJDXBluejay DiagnosticsN/A2.712.71LGMKLogicMarkN/A3.733.29NAYANAYA BiosciencesN/A0.230.20NDRAENDRA Life SciencesN/A3.853.85Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBJDXBluejay Diagnostics18.47%LGMKLogicMark7.88%NAYANAYA Biosciences12.02%NDRAENDRA Life Sciences1.19%Insider OwnershipCompanyInsider OwnershipBJDXBluejay Diagnostics0.08%LGMKLogicMark2.17%NAYANAYA Biosciences1.79%NDRAENDRA Life Sciences0.04%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBJDXBluejay Diagnostics91.49 million1.49 millionNot OptionableLGMKLogicMark20576.31 million2.65 millionNo DataNAYANAYA Biosciences10666,0004.40 millionN/ANDRAENDRA Life Sciences20740,000738,000Not OptionableNAYA, NDRA, LGMK, and BJDX HeadlinesRecent News About These CompaniesENDRA Life Sciences Inc News (NDRA) - Investing.comJuly 3, 2025 | investing.comENDRA Life Sciences Inc. (NDRA) - Yahoo FinanceJune 25, 2025 | finance.yahoo.comENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold StandardJune 16, 2025 | finance.yahoo.comENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | businesswire.comENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business UpdateMarch 31, 2025 | finance.yahoo.comENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 TherapiesMarch 31, 2025 | businesswire.comENDRA Life Sciences Inc Registered Shs NDRAFebruary 2, 2025 | morningstar.comMWhat Makes ENDRA Life Sciences (NDRA) a New Strong Buy StockJanuary 28, 2025 | zacks.comENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price RequirementNovember 22, 2024 | businesswire.comENDRA Life Sciences Reports Q3 2024 Results and ProgressNovember 16, 2024 | markets.businessinsider.comENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business UpdateNovember 15, 2024 | finance.yahoo.comStudy Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024November 12, 2024 | finance.yahoo.comENDRA Life Sciences Inc trading halted, news pendingNovember 6, 2024 | markets.businessinsider.comENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European PatentNovember 6, 2024 | finance.yahoo.comWave Life Sciences: Pioneering RNA-Editing with Promising Obesity and Cardiovascular InnovationsNovember 4, 2024 | markets.businessinsider.comWave Life Sciences: Pioneering RNA Editing Technology with Promising Therapeutic PipelineOctober 31, 2024 | markets.businessinsider.comWhat’s Driving ENDRA Life Sciences Inc (NDRA) Stock’s 36.45% Surge Over the Past Month?October 28, 2024 | bovnews.comBEndra activates TAEUS system to initiate clinical study at LMU in GermanyOctober 23, 2024 | markets.businessinsider.comLife sciences investor Dimension seeks to raise $500M second fundOctober 23, 2024 | endpts.comEWhy ENDRA Life Sciences (NDRA) Stock Is Up 140%October 23, 2024 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNAYA, NDRA, LGMK, and BJDX Company DescriptionsBluejay Diagnostics NASDAQ:BJDX$1.61 -0.03 (-1.83%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.62 +0.01 (+0.93%) As of 09:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.LogicMark NASDAQ:LGMK$0.0032 +0.00 (+6.67%) As of 07/16/2025 03:58 PM EasternLogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company's devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one's health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.NAYA Biosciences NASDAQ:NAYA$0.80 +0.01 (+1.65%) As of 07/15/2025NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.ENDRA Life Sciences NASDAQ:NDRA$7.23 -0.84 (-10.41%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$7.28 +0.05 (+0.75%) As of 09:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Super Micro Stock May Benefit as Cooling Demand Takes Off Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
